Cangzhou Huachen Biotechnology Co. LTD

Cangzhou Huachen Biotechnology Co., Ltd. was established on October 31, 2017, located in the Lingang Economic and Technology Development Zone, Bohai New District, Cangzhou, with a registered capital of 100 million yuan and a total area of 100 acres. Our company has been awarded the honorary title of 3A-level credit enterprise. Based on the research and production of amino acids as well as its derivatives, we are committed to the high-tech industrialization in the field of biomedicine.
The company was invested and acquired by Grand Pharma (China) Co., Ltd. in October 2021. Grand Pharma (China) Co., Ltd. continues to focus on technological breakthroughs and research in the amino acid industry, relying on technological and cost advantages, combined with our internal amino acid industry chain to strengthen the core competitiveness of our company.

At present, we have built a 30,000-ton industrial-grade glycine project with a total investment of 420 million yuan, annual capacity is 30,000 tons. Glycine is mainly used in pesticide intermediates (such as glyphosate), feed additives and food additives etc.

Our facilities contain modern workshops and equipment, production process is strictly controlled in accordance with quality standards, with a complete quality  control system, high-skilled production personnel, strong technical research and development capabilities.The company adheres to the business philosophy of "high quality, specialization and internationalization", based on scientific standardized operation procedures and perfect quality management system, we provide products to customers with high quality and stable supply.

Cangzhou Huachen Biotechnology Co., Ltd., is committed to becoming a global professional Glycine manufacturer, creating value for customers, making unremitting efforts to a healthier and better life for human being.